Security readout for executives and security teams
This issue affects SAS Drug Development before 32DRG02. After logout, a previously authenticated user may still reach resources by using the browser back or forward buttons. The main concern is unauthorized viewing from a shared or unattended workstation after a legitimate session ends. Exposure appears limited to organizations running SAS Drug Development versions before 32DRG02, especially on shared workstations or environments handling sensitive study data. The bundled structured affected data is not normalized, so asset owners should verify product/version directly. Treat this as a targeted hygiene issue for legacy SAS Drug Development environments, not a broad internet-scale emergency. Prioritize if the system handles regulated clinical or drug-development data, or if users commonly share workstations. Mitigation focus: Identify any SAS Drug Development deployments and their exact maintenance level.; Review SAS 32DRG02 release notes and vendor guidance for the logout fix.; Upgrade or apply the relevant SAS-provided hotfix where applicable..
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2007-6763 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.